Veerhealth Care is currently trading at Rate RS 20.02, up by 0.01 points or 0.05% from its previous closing of Rate RS 20.01 on the BSE.

The stock opened at Rate RS 19.85 and has touched an intraday high and low of Rate RS 20.50 and Rate RS 19.85 respectively. A total of 6,138 shares have been traded so far on the counter.

The BSE group 'X' stock, with a face value of Rate RS 10, has recorded a 52-week high of Rate RS 27.00 on July 26, 2024, and a 52-week low of Rate RS 9.29 on March 4, 2025. Over the last week, the stock has traded between a high of Rate RS 21.20 and a low of Rate RS 19.31.

The company's current market capitalization stands at Rate RS 40.04 crore. Promoter holding in the company is 31.50%, while non-institutional investors hold the remaining 68.50%.

Veerhealth Care has entered into a strategic contract manufacturing agreement with a top-ranking company in the personal care segment on leading marketplace platforms in India. Under the agreement, Veerhealth will manufacture and supply private-label personal care products exclusively tailored to the client’s brand specifications and quality benchmarks.

Regulatory approvals are currently in process and are expected to be completed soon, with commercial production likely to commence shortly. This partnership is anticipated to positively impact Veerhealth Care’s revenue and capacity utilization in the coming quarters.

Veerhealth Care is primarily engaged in the trading, manufacturing, and marketing of research-based Ayurvedic medicines.